RB1: The Retinoblastoma Protein | Community Health

The RB1 gene, which encodes the retinoblastoma protein, is a tumor suppressor gene that plays a critical role in regulating cell growth and division. First identified in 1986 by researchers Thaddeus Dryja and Webster Cavenee, RB1 has been found to be mutated in a wide range of cancers, including retinoblastoma, breast cancer, and lung cancer. The protein works by binding to and inhibiting the activity of transcription factors that promote cell proliferation, thereby preventing excessive cell growth. With a vibe rating of 8, RB1 is a highly influential gene in the field of cancer research, with over 2,500 research papers published on the topic in the last decade alone. The study of RB1 has led to a greater understanding of the molecular mechanisms underlying cancer development and has informed the development of targeted therapies. As research continues to uncover the complexities of RB1's role in cancer, it is likely that our understanding of this gene will continue to evolve, with potential implications for the diagnosis and treatment of a wide range of cancers.